Last week, Pfizer announced that it was “temporarily” slowing vaccine supplies to Europe because manufacturing changes to boost vaccine output.

Several days later, AstraZeneca announced that its deliveries to the EU will fall be cut for a few weeks because of “a production glitch”.

Sound familiar (well, not the part about AstraZeneca, but the part about Pfizer).

So how did the EU react?

Well, according to European Council President Charles Michel, “We (presumably the heavies at the EU) banged our fist on the table“, so that later in the same week, Pfizer announced that “delays of several weeks had turned into a slowdown of deliveries.”

Something about the squeaky wheel . . .

“We banged our fist on the table and finally announced delays of several weeks turned into a slowdown of deliveries,” he said.